Schatzman Randall C 5
5 · Bolt Biotherapeutics, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 5
Schatzman Randall C
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-12-06$0.78/sh+2,500$1,955→ 12,859 total - Purchase
Common Stock
2023-06-06$1.18/sh+2,500$2,954→ 10,359 total
Footnotes (1)
- [F1]Shares acquired under the issuer's Employee Stock Purchase Plan.